WHO To Convene MERS Virus Panel

An expert committee will decide whether to escalate efforts to combat the novel coronavirus that is spreading throughout the Middle East.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Micrograph of Middle East respiratory syndrome coronavirus particles (yellow)FLICKR, NIAIDThe World Health Organization (WHO) will convene an emergency committee on Tuesday (July 9) to determine whether a new coronavirus that is responsible for 42 deaths, mostly in Saudi Arabia, constitutes a “public health emergency of international concern,” according to Keiji Fukuda, the WHO’s assistant director-general for Health and Environment, who announced the plan at a press conference on Friday (July 5) in Geneva. Names of committee members will be released later today.

Middle East respiratory syndrome (MERS) is in the same family of flu-like coronaviruses as the deadly SARS virus that killed 775 people in China in 2003. Since the MERS virus first appeared in September 2012 in Saudi Arabia, the WHO has confirmed 79 cases in Jordan, Qatar, Saudi Arabia, the United Arab Emirates (UAE), France, Germany, Italy, Tunisia, and Britain. MERS has not been seen in the United States.

According to a report published online Friday (July 5) in The Lancet by a team of French epidemiologists, MERS is less transmissible than measles, smallpox, or strong strains of the flu. The researchers conclude that the low level of infectiousness of MERS means it does not have the potential to create a pandemic.

So far the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies